Wells Fargo’s $15 target on IART

IART Integra Lifesciences Holdings Corp

$12.7 → $15 (+18%) by Oct 2027

Equal Weight · lowers · said Oct 5, 2026 · 12-month default horizon

Open: judged on the close on Oct 5, 2027

The article this target came from

Wells Fargo cuts Integra LifeSciences price target on lower revenue outlook

Investing.com · Oct 5, 2026

Investing.com - Wells Fargo lowered its price target on Integra LifeSciences shares (NASDAQ:IART) to $15 from $18 while maintaining an Equal Weight stock rating.

Wells Fargo’s track record → Integra Lifesciences Holdings Corp →

A fact about what Wells Fargo published, as reported by Investing.com, not a recommendation from Dalsna Finance; Wells Fargo is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.